Will the world ever be ready for solar geoengineering?
Many object to shielding the planet from the sun’s rays by injecting particles into the atmosphere, but a small band of researchers think the approach is worth studying before it’s too late
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2024 American Chemical Society
March 26, 2018 Cover
Volume 96, Issue 13
Many object to shielding the planet from the sun’s rays by injecting particles into the atmosphere, but a small band of researchers think the approach is worth studying before it’s too late
Volume 96 |
Issue 13
Quote of the Week
Climate Change
3-D printer emissions raise concerns and prompt controls
Scientists want to set a voluntary standard that manufacturers compete to meet
Scientific instrument makers at Pittcon predict sunny days ahead
A strong global economy contributes to a robust outlook for instrument sales, particularly for drug research
-
The Enabling Technologies Consortium fills in pharma technology gaps
Consortium works with outside vendors to improve supporting technologies for drug development
-
Scientists at India’s government labs struggle to adjust to changing priorities
Budget cuts and emphasis on applied research challenge the Council of Scientific & Industrial Research
-
Wendy Young, Genentech’s new head of small molecules, is ready to take on the drug industry’s toughest targets
Seasoned drug hunter sees untapped potential in protein degraders, macrocycles, and more
ADVERTISEMENT
Science Concentrates
New Orleans hosts ACS national meeting
Council selects 2019 nominees for president-elect, raises membership fee to $175
Business & Policy Concentrates
- China upgrades environment ministry in reshuffling
- EU forces Celanese to abandon acetate joint venture, approves Bayer-Monsanto deal, with conditions
- Third Rock-founded Rheos Medicines launches to tackle immunometabolism
- Monsanto joins with Pairwise to develop base-edited crops
- M&G assets being sold off
